ARTICLE | Clinical News
Angiox bivalirudin regulatory update
August 2, 2010 7:00 AM UTC
The Medicines Co. said that Hospira Inc. (NYSE:HSP, Lake Forest, Ill.) filed a Paragraph IV certification as part of an ANDA for a generic bivalirudin. The Medicines Co. markets the anticoagulant as ...